A higher level of IgM anti-oxidized LDL antibodies is associated with a lower severity of coronary atherosclerosis in patients on statins

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 263-264

  Garrido Sanchez L ^a,b   Chinchurreta, P ^c   Garcia Fuentes E ^a,d   Mora, M ^c   Tinahones, F J ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d Hospital University Carlos Haya de Málaga   (Spain)

Author keywords

Anti oxidized LDL antibodies; Atherosclerosis; Oxidized LDL; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN M ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ANGIOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 78650007278     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.09.472     Document Type: Article

References (18)

1. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126 [Review]
2. P.X. Shaw Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it Arch Immunol Ther Exp (Warsz) 52 2004 225 239 [Review]
3. Y. Shoenfeld, R. Wu, L.D. Dearing, and E. Matsuura Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110 2004 2552 2558
4. T. Lehtimäki, S. Lehtinen, and T. Solakivi Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease Arterioscler Thromb Vasc Biol 19 1999 23 27
5. J. Karvonen, M. Päivänsalo, Y.A. Kesäniemi, and S. Hörkkö Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis Circulation 108 2003 2107 2112
6. M. Evans, A. Roberts, S. Davies, and A. Rees Medical lipid-regulating therapy: current evidence, ongoing trials and future developments Drugs 64 2004 1181 1196 [Review]
7. G.D. Norata, A. Pirillo, and A.L. Catapano Statins and oxidative stress during atherogenesis J Cardiovasc Risk 10 2003 181 189 [Review]
8. C. Orem, A. Orem, H.A. Uydu, S. Celik, C. Erdöl, and B.V. Kural The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status Coron Artery Dis 13 2002 65 71
9. J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men Arterioscler Thromb Vasc Biol 21 2001 101 107 (Pubitemid 32063236)
10. S. Tsimikas, E.S. Brilakis, and R.J. Lennon Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events J Lipid Res 48 2007 425 433
11. M. Fukumoto, T. Shoji, M. Emoto, T. Kawagishi, Y. Okuno, and Y. Nishizawa Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population Arterioscler Thromb Vasc Biol 20 2000 703 707
12. F.J. Tinahones, J.M. Gómez-Zumaquero, and L. Garrido- Sánchez Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population J Lipid Res 46 2005 452 457
13. F.J. Tinahones, J.M. Gómez-Zumaquero, and G. Rojo-Martínez Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population Metabolism 51 2002 429 431
14. L. Garrido-Sánchez, F. Cardona, and E. García-Fuentes Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus Eur J Clin Invest 38 2008 615 621
15. L. Garrido-Sánchez, J.M. García-Almeida, and S. García-Serrano Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients Diabetes Care 31 2008 2258 2264
16. S. Hörkkö, D.A. Bird, and E. Miller Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins J Clin Invest 103 1999 117 128
17. X. Zhou, G. Caligiuri, A. Hamsten, A.K. Lefvert, and G.K. Hansson LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 108 114
18. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150